Importantly, genetic or pharmacologic suppression of ACSL3 is cytotoxic to ccRCC cells in vitro and causes a reduction of tumor weight in an orthotopic mouse model. This evidence concerns the gene ACSL3 and nonpapillary renal cell carcinoma.